ZOLEA, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 186
EU - Europa 101
AS - Asia 24
AF - Africa 6
OC - Oceania 1
Totale 318
Nazione #
US - Stati Uniti d'America 180
UA - Ucraina 49
DE - Germania 22
SE - Svezia 11
CN - Cina 9
SG - Singapore 8
AT - Austria 7
CA - Canada 6
SN - Senegal 6
IT - Italia 5
TR - Turchia 5
FI - Finlandia 3
BE - Belgio 2
FR - Francia 2
KR - Corea 2
AU - Australia 1
Totale 318
Città #
Chandler 44
Jacksonville 28
San Mateo 23
Dearborn 11
New York 8
Lawrence 7
Roxbury 7
Ashburn 6
Dakar 6
Ottawa 6
Izmir 5
Wilmington 5
Des Moines 4
Beijing 3
Helsinki 3
Rende 3
Singapore 3
Vienna 3
Brooklyn 2
Brussels 2
Cambridge 2
Fremont 2
Inglewood 2
Seoul 2
Ann Arbor 1
Bremen 1
Hanover 1
Los Angeles 1
Melbourne 1
Norwalk 1
Ogden 1
Palermo 1
Redmond 1
San Francisco 1
Shanghai 1
Totale 198
Nome #
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 62
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 58
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 55
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 41
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 39
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 38
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 34
Totale 327
Categoria #
all - tutte 2.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 5 5 0 7 2 12 2 5 4 0 8 2
2020/202158 10 5 7 7 1 5 0 7 4 7 0 5
2021/202282 0 13 0 7 7 1 2 24 1 0 10 17
2022/202377 13 12 6 14 9 9 0 4 5 3 0 2
2023/202438 1 3 6 1 2 12 1 0 2 3 1 6
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 327